47
Growth Score in past quarter
pts
Heat Score 47 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
735741
Meabco A/S is a Danish biotech company developing cancer treatment products to improve patients' life with cancer.
- SERGEY PIGAREV: CTO
- FREDRIK SIWMARK: CSO
About the Company
De forskellige lægemidler, der anvender den teknologi, Meabco har udviklet, har flere fordele: For det første kan de bekæmpe kræft og beskytte mod/helbrede strålingsinducerede skader, for det andet kan de afbalancere immunsystemet og blodværdierne samt andre kropsfunktioner.
Meabco har patent på sin produktportofolio, således at patenterne
dækker alle produkter samt produktion, administration, kompositioner og anvendelse. Patentbeskyttelsen varer frem til 2033, og geografisk dækker patentbeskyttelsen de vigtigste markeder inden for lægemiddelindustrien.